Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Robert J. Carney"'
Autor:
Robert J. Carney, Saurabh Gupta, Tesfaldet T. Michael, Muhammad A Khan, Alexandra M. Lansky, Abbas Shehadeh, Uwe Zeymer, Gert Richardt
Publikováno v:
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventions. 92(6)
OBJECTIVES To evaluate the safety and efficacy of the PRO-Kinetic Energy (PKE) Cobalt Chromium Coronary Stent System (BIOTRONIK AG, Switzerland). BACKGROUND Percutaneous coronary intervention is a mainstay treatment for symptomatic coronary artery di
Autor:
Elliott M. Antman, Charles Lazzam, Robert J. Carney, Raymond G. McKay, Govinda Weerakkody, Stephen D. Wiviott, Kenneth J. Winters, Sabina A. Murphy, Eugene Braunwald, Bruce D. Behounek, Carolyn H. McCabe
Publikováno v:
Circulation. 111:3366-3373
Background— Despite the current standard antiplatelet regimen of aspirin and clopidogrel (with or without glycoprotein IIb/IIIa inhibitors) in percutaneous coronary intervention patients, periprocedural and postprocedural ischemic events continue t
Publikováno v:
Managerial Finance. 28:9-26
Reports that under a third of the increasing numbers of US citizens needing long‐term care (LTC) in a nursing home pay their own fees; and that Medicaid (health programme for the poor) meets over half of LTC costs. Describes the rules applied to qu
Autor:
Abbas Shehadeh, Robert J. Carney, Muhammed Akram Khan, Uwe Zeymer, Gert Richardt, Tesfaldet T. Michael, Saurabh Gupta, Alexandra J. Lansky
Publikováno v:
JACC: Cardiovascular Interventions. 10:S59
Percutaneous Coronary Intervention (PCI) is one of the main stay treatments for symptomatic coronary artery disease. While drug-eluting stents (DES) constitute a majority of implants, bare-metal stents (BMS) remain important for a subset of patients
Autor:
Lise Graham, Robert J. Carney
Publikováno v:
Managerial Finance. 24:25-44
Notes increasing US support for the BTID insurance strategy, i.e. buy low cost term life insurance and invest the difference between the cost of this and of whole life insurance. Points out some other investment possibilities and compares the termina
Autor:
Christopher M. O'Connor, Roderick B. Meese, Steven McNulty, Kathi D. Lucas, Robert J. Carney, Renee M. LeBoeuf, William Maddox, Charles F. Bethea, Neal Shadoff, Thomas F. Trahey, James A. Heinsimer, John M. Burks, Gerard O'Donnell, Mitchell W. Krucoff, Robert M. Califf, null The DUCCS-II Investigators
Publikováno v:
The American Journal of Cardiology. 77:791-797
The focus of new research efforts to improve the morbidity and mortality associated with acute myocardial infarction (AMI) has turned to adjuvant agents that show promise of improving outcomes following coronary thrombolysis. We enrolled 162 patients
Autor:
Patrick J. Daley, Harvey J. White, Robert J. Carney, Suzanne K. Vermilya, Ernest Pickering, Gregory A. Murphy, Sam L. Teichman, Thomas R. Brandt, Timothy J. McDonough
Publikováno v:
Journal of the American College of Cardiology. 20(1):17-23
Clot dissolution with restoration of infarct-related artery blood flow is the likely mechanism for the improved prognosis and mortality reduction seen after thrombolytic therapy of acute myocardial infarction. A pilot study has suggested that 100 mg
Autor:
Robert J. Carney, Donald W. Hardigree
Publikováno v:
Journal of Insurance Issues. 13(2):1-23
Autor:
Stephen D, Wiviott, Elliott M, Antman, Kenneth J, Winters, Govinda, Weerakkody, Sabina A, Murphy, Bruce D, Behounek, Robert J, Carney, Charles, Lazzam, Raymond G, McKay, Carolyn H, McCabe, Eugene, Braunwald
Publikováno v:
Circulation. 111(25)
Despite the current standard antiplatelet regimen of aspirin and clopidogrel (with or without glycoprotein IIb/IIIa inhibitors) in percutaneous coronary intervention patients, periprocedural and postprocedural ischemic events continue to occur. Prasu
Autor:
Karl Jacoby, Robert J. Carney
Publikováno v:
The Annals of Iowa. 60:301-301